Childhood Stress Linked to Higher Risk of Heart Disease in Adulthood

Translate to Spanish or other 102 languages!

Researchers stress during childhood can lead to health issues in adulthood. Image for illustration purposes
Researchers stress during childhood can lead to health issues in adulthood. Image for illustration purposes
- Advertisement -
  • Researchers are reporting that stress early in life can contribute to cardiometabolic diseases in adulthood.
  • They say that’s because high levels of stress hormones may contribute to heart disease.
  • Experts say there are a number of ways parents can help children understand and deal with stress.

Stress in adolescence and early adulthood may contribute to the development of cardiometabolic diseases later in life, according to a studyTrusted Source published today in the Journal of the American Heart Association.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/childhood-stress-linked-to-higher-risk-of-heart-disease-in-adulthood?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-01-18&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Dogs Benefit Mind and Soul

"Dogs are wonderful greeters. They're waiting for you to come home, and they're always happy to see you. In turn, this increases our feel-good hormones, like dopamine and serotonin,” explained Chivonna Childs, PhD.

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -